This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
Accession | PRJNA746323; GEO: GSE180039 |
Type | Umbrella project |
Publications | Sharma MD et al., "Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity.", Immunity, 2021 Oct 12;54(10):2354-2371.e8 |
Submission | Registration date: 13-Jul-2021 2125 K, Georgia Cancer Center, Augusta University |
Relevance | Superseries |
Project Data:
Resource Name | Number of Links |
---|
Sequence data |
SRA Experiments | 10 |
Publications |
PubMed | 1 |
PMC | 1 |
Other datasets |
BioSample | 10 |
GEO DataSets | 4 |
Bruton’s tyrosine kinase (BTK) and indoleamine 2,3-dioxygenase (IDO) block differentiation of inflammatory dendritic cells in tumors encompasses the following 3 sub-projects:
Project Type | Number of Projects |
Epigenomics | 1 |
BioProject accession | Organism | Title |
---|
PRJNA746298 | Mus musculus | Bruton’s tyrosine kinase (BTK) and indoleamine 2,3-dioxygenase (IDO) block differentiation of inflammatory dendritic cells in tumors [ATAC-seq] (2125 K, Georgia Cancer Center,...) |
|
Transcriptome or Gene expression | 2 |
BioProject accession | Organism | Title |
---|
PRJNA746405 | Mus musculus | Bruton’s tyrosine kinase (BTK) and indoleamine 2,3-dioxygenase (IDO) block differentiation of inflammatory dendritic cells in tumors [scRNA-seq] (2125 K, Georgia Cancer Center,...) | PRJNA746314 | Mus musculus | Bruton’s tyrosine kinase (BTK) and indoleamine 2,3-dioxygenase (IDO) block differentiation of inflammatory dendritic cells in tumors [Bulk RNA-seq] (2125 K, Georgia Cancer Center,...) |
|